TyraTech set to sell new insect repellent in US
TyraTech enjoyed a bounce after announcing its new insect repellent had been granted registration in the US, leaving it just one step short of being on the shelves.
TyraTech enjoyed a bounce after announcing its new insect repellent had been granted registration in the US, leaving it just one step short of being on the shelves.
The firm's personal insect repellent 'NO-SKEETO!' now has registration in 49 States and the District of Columbia.
This news means the product is approved and ready for immediate sale in retail channels, and caused shares to jump 9.5%.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The company is now in the process of evaluating global commercial and retail partners for the product.
It has also filed for patent protection for its NO-SKEETO! formulation and has submitted data from laboratory and field trials for publication in two international journals.
TyraTech's Vice President of Research & Development, Dr. Keith Kennedy, said diseases transmitted by mosquitoes and ticks continued to be an increasing problem in North America.
'The number of West Nile Virus cases reported in the US so far this year was the highest number recorded by the Centers for Disease Control in the last 10 years," he said.
"The incidence of Lyme disease continues to exceed more than 30,000 cases per year."
Sign up for MoneyWeek's newsletters
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
-
Trump wants to colonise Mars – will it happen?
Donald Trump wants to plant the US flag on Mars. Could humans really live there?
By Simon Wilson
-
Klarna postpones US IPO as Trump's tariffs rattle markets
Buy-now-pay-later lender Klarna has postponed its US initial public offering owing to the market turbulence. It is not alone, says Matthew Partridge
By Dr Matthew Partridge